Stockscreener 앱 받기
27.43
5.64%
-1.64
시장 영업 전:
26.98
-0.45
-1.64%
전일 마감가:
$29.07
열려 있는:
$29.32
하루 거래량:
467.95K
Relative Volume:
37.44
시가총액:
$1.15B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.00%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$25.44
$29.64
1주일 범위
$25.44
$30.67
52주 변동 폭
$25.44
$30.67
Avalyn Pharma Inc Stock (AVLN) Company Profile
Compare AVLN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVLN
Avalyn Pharma Inc
|
27.43 | 1.15B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Avalyn Pharma Inc 주식(AVLN)의 최신 뉴스
Avalyn brings patient feedback on lung fibrosis care to ATS 2026 - Stock Titan
Avalyn to Present Patient-Centered Research on AP01 - GlobeNewswire
Lung disease drug developer Avalyn surges on public debut - MSN
Preferred dividends of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Cash per share of Avalyn Pharma Inc. – BOATS:AVLN - TradingView
Avalyn Pharma (AVLN) Stock Trends and Sentiment 2026 - MarketBeat
Avalyn Pharma (AVLN) 10K Form and Latest SEC Filings 2026 - MarketBeat
Finance Watch: Avalyn, Hemab And Seaport Launch $856m Worth Of IPOs - Citeline News & Insights
Avalyn Pharma completes $345 million IPO on nasdaq - Investing.com
Avalyn Pharma completes $345 million IPO on nasdaq By Investing.com - Investing.com Canada
Avalyn Pharma closes $345 million IPO on Nasdaq - Investing.com
Avalyn raises $345M as underwriters take all extra IPO shares - Stock Titan
Avalyn Pharma Inc. (AVLN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Avalyn Announces Closing of Initial Public Offering and - GlobeNewswire
Avalyn Pharma Inc. (AVLN) Stock Price Today & Analysis - Gotrade
AVLN Price Today: Avalyn Pharma Inc. Stock Price, Quote & Chart | MEXC - MEXC
Avalyn Pharma (AVLN): Upsized and Oversubscribed, Avalyn Pharma Delivers Breakout IPO - Smartkarma
EDGAR Filing Documents for 0001193125-26-197686 - SEC.gov
Avalyn Pharma Inc.(NasdaqGS: AVLN) added to NASDAQ Composite Index - marketscreener.com
Avalyn Pharma raises $300M in IPO, shares surge 64% on first day of trading - The Business Journals
Goodwin, Davis Polk Lead Avalyn's Upsized $300M IPO - Law360
Novo-Backed Drugmaker Avalyn Soars 44% After $300 Million US IPO - Bloomberg.com
Is Avalyn Pharma (NASDAQ:AVLN) In A Good Position To Invest In Growth? - Yahoo Finance
Pulmonary drug developer Avalyn surges on IPO (AVLN:NASDAQ) - Seeking Alpha
Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials - MedCity News
Mists of Avalyn thicken with $300M IPO for inhaled drugs - BioWorld News
Avalyn Pharma prices $300M IPO at $18 per share - MSN
Avalyn Pharma IPO ends oversubscribed with concentrated allocations - Investing.com
Avalyn Pharma Rings the Opening Bell - Nasdaq
Avalyn Pharma Inc (AVLN) Stock Price, News & Analyst Forecast - eToro
Avalyn Sets IPO Price At $18 Per Share - RTTNews
IPO Tracker 2026: Avalyn beats expectations with $300M debut - BioSpace
Avalyn prices upsized IPO at $18 per share, raising $300 million - Investing.com
Avalyn Pharma prices upsized IPO at $18 per share for $300 million - Investing.com
Avalyn Pharma raises $300M in IPO - Axios
Novo-Backed Drugmaker Avalyn Raises $300 Million in Upsized IPO - Bloomberg.com
Avalyn Pharma prices upsized IPO at $18 per share - Investing.com
Avalyn, in pursuit of better lung drugs, banks $300M in an IPO - BioPharma Dive
Avalyn Announces Pricing of Upsized Initial Public Offering - The Manila Times
AVLN : Avalyn Pharma Key Company Details - Zacks Investment Research
AVLN : AVALYN PHARMA Key Company Metrics & Non-finance Metrics - Zacks Investment Research
EDGAR Filing Documents for 0001193125-26-189477 - SEC.gov
Avalyn Pharma Inc. Income Statement – NASDAQ:AVLN - TradingView
Avalyn Pharma Inc. Dividends – NASDAQ:AVLN - TradingView
Net income before discontinued operations of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
AVALYN PHARMA INC Balance Sheet – NASDAQ:AVLN - TradingView
Total debt of Avalyn Pharma Inc. – NASDAQ:AVLN - TradingView
Free cash flow of AVALYN PHARMA INC – NASDAQ:AVLN - TradingView
AVALYN PHARMA INC Earnings and Revenue – NASDAQ:AVLN - TradingView
Avalyn Strengthens Leadership Team to Support Long-Term Growth with Appointments of Industry Leaders Adam Golden and Frank Salisbury - Yahoo Finance
Basic earnings per share (basic EPS) of AVALYN PHARMA INC – NASDAQ:AVLN - TradingView
Avalyn Pharma Inc (AVLN) 재무 분석
Avalyn Pharma Inc (AVLN)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):